International Journal of
Reproductive Biomedicine
Thu, Apr 25, 2024
[Archive]
Volume 11, Issue 11 (12-2013)
IJRM 2013, 11(11): 861-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Borna S, Shariat M, Fallahi M, Janani L. Prevalence of immunity to Toxoplasmosis among Iranian childbearing age women: Systematic review and meta-analysis. IJRM 2013; 11 (11) :861-0
URL: http://ijrm.ir/article-1-368-en.html
URL: http://ijrm.ir/article-1-368-en.html
1- Maternal-Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
2- Breast Feeding Research Center, Tehran University of Medical Sciences, Tehran, Iran , dr.fallahi2020@yahoo.com
3- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2- Breast Feeding Research Center, Tehran University of Medical Sciences, Tehran, Iran , dr.fallahi2020@yahoo.com
3- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (2815 Views)
Background: Our information regarding immunity to toxoplasmosis among reproductive age women is indeterminate and there is significant variation between reported results; it is necessary to perform a Meta-analysis study on subjects to obtain required findings and develop preventive measures accordingly.
Objective: Estimation level of immunity to toxoplasmosis in reproductive ages.
Materials and Methods: All published papers in main national and international databases were systematically searched for some specific keywords to find the related studies up to 2012. we selected only original articles that either reported percentage of positive anti Toxoplasma IgG or total anti toxoplasma antibody by using ELISA or IFAT method (provided that the titer ≥1.20 is considered positive for IFAT) in childbearing age women and the full text of papers were found too.
Results: Studies involved a total of 13480 participants. The maximum and minimum reported prevalence rates of anti-Toxoplasma IgG antibody using IFTA serological method were 21.8% and 54%; using ELISA serological method were 23% and 64%, respectively. The overall estimation for prevalence of anti-Toxoplasma IgG antibody using IFTA serological method was 34.5% (95% CI: 28.5-40.5); using ELISA method was 37.6% (95% CI: 30.4-44.9). The overall estimation for prevalence of anti-Toxoplasma total antibody was 39.9% (95% CI: 26.1-53.7).
Conclusion: In Iran, screening is not routinely performed yet. The incidence of toxoplasmosis is too high to justify routine screening. Prenatal screening can help to identify mothers susceptible to infection. Screening for the presence of antibodies allows primary prevention of toxoplasmosis infection where eating habits and hygiene practices have clearly been identified as risk factors.
Objective: Estimation level of immunity to toxoplasmosis in reproductive ages.
Materials and Methods: All published papers in main national and international databases were systematically searched for some specific keywords to find the related studies up to 2012. we selected only original articles that either reported percentage of positive anti Toxoplasma IgG or total anti toxoplasma antibody by using ELISA or IFAT method (provided that the titer ≥1.20 is considered positive for IFAT) in childbearing age women and the full text of papers were found too.
Results: Studies involved a total of 13480 participants. The maximum and minimum reported prevalence rates of anti-Toxoplasma IgG antibody using IFTA serological method were 21.8% and 54%; using ELISA serological method were 23% and 64%, respectively. The overall estimation for prevalence of anti-Toxoplasma IgG antibody using IFTA serological method was 34.5% (95% CI: 28.5-40.5); using ELISA method was 37.6% (95% CI: 30.4-44.9). The overall estimation for prevalence of anti-Toxoplasma total antibody was 39.9% (95% CI: 26.1-53.7).
Conclusion: In Iran, screening is not routinely performed yet. The incidence of toxoplasmosis is too high to justify routine screening. Prenatal screening can help to identify mothers susceptible to infection. Screening for the presence of antibodies allows primary prevention of toxoplasmosis infection where eating habits and hygiene practices have clearly been identified as risk factors.
Type of Study: Original Article |
References
1. Saeidi M, Bakhshandehnosrat S, Ghaemi EA, Hedayat Mofidi SM, Kohsar F, Behnampour N. [The prevalency of toxoplasma antibodies in women during marriage consultation in Gorgan]. J Gorgan Uni Med Sci 2002; 4: 64-71. (In Persian)
2. Gilbert R. Toxoplasmosis and pregnancy. Available at: http:// www. uptodate. com/ contents/ toxoplasmosis-and-pregnancy.
3. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of Toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J 2008; 14: 163-171.
4. Fouladvand M, Barazesh A, Zandi K, Naeimi B, Tajbaksh S. Seroepidemiological study of toxoplasmosis in childbearing age women in Bushehr city, south west of Iran in 2009. Afr J Biotech 2010; 9: 5809-5812.
5. Falah E, Majidi J, Navazesh R, Kushavar H, Mahdipourzare N. [An epidemiological study of toxoplasma infection among high-school girls in Jolfa]. J Reprod Infertil 2005; 6: 261-269. (In Persian)
6. Gharavi MJ. [Seroepidemiological survey of toxoplasmosis in pregnant women in Tehran]. Hakim Res J 2002; 5: 91-98. (In Persian)
7. Manouchehri-Naeini K, Keshavarz H, Abdizadeh-Dehkordi R, Zebardast N, Kheiri S, Khalafian P, et al. [Seroprevalence of anti-Toxoplasma antibodies among pregnant women from Chaharmahal and Bakhtyari province using indirect immunoflurescent in 2006-2007]. Shahrekord Uni Med Sci J 2006; 8: 74-80. (In Persian)
8. Rafiei A, Hemadi A, Amani F. [Seroepidemiology of toxoplasmosis among girls students Ahwaz Joundishapoor University of medical sciences]. Iran J Infect Dis Trop Med 2005; 10: 35-42. (In Persian)
9. Haghdoost AA, Sadeghirad B, Hajarizadeh B, Mirzazadeh A. The application of systematic review and meta-analysis concepts in summarizing the findings of observational studies. Iran J Psychiatry 2007; 2: 132-136.
10. Manochehri K, Deris F, Zebardast N. [The immunity status of the rural pregnant woman in Chaharmahal and Bakhtyari province against Toxoplasma infection, 2001-2002]. Shahrekord Univ Med Sci J 2004; 6: 63-72. (In Persian)
11. Barooti E, Rezazadehkermani M, Sadeghirad B, Motaghipisheh Sh, Tayeri S, Arab M, et al. Prevalance of Iron deficiency anemia among Iranian pregnant woman; a systematic review and meta-analysis. J Reprod Infertil 2010; 11: 17-24.
12. Taravati M, Khalili FS, Hazrati Kh, Babazadeh H, Basharat S. [Evaluation of IgG and IgM anti-Toxoplasma Gondii antibodies among women before marriage in Urmia health centre]. J Urmia Univ Med Sci 2002; 13: 109-117. (In Persian)
13. Mardani A, Keshavarz H. [Seroepidemiologic evaluation of toxoplasmosis in pregnant women by ELISA and IFA in Qom]. Iran J Infect Dis Trop Med 2004; 9: 46-52. (In Persian)
14. Arbabi M, Talari SA. [The prevalence of Toxoplasmosis in subjects involved in meat industry and pregnant women in Kashan]. Feyz 2002; 6: 28-38. (In Persian)
15. Talari SA, Namaki S, Khorshidimal Ahmadi A.[Seroepidemiology of Toxoplasma Gondii in parturients referring to Shabieh Khani hospital, Khashan, 1990-1993]. J Med Res 2000; 25: 243-248. (In Persian)
16. Sotodeh Jahromi A, Safa O, Zarea Sh, Davodian P, Farshidfar Gh. [Prevalence of toxoplasma antibodies in pregnant women referring to Shariati hospital Bandar Abbas,Iran,1999-2000]. Med J Hormozgan Univ 2002; 6: 25-30. (In Persian)
17. Talari SA, Hejazi Sh, Rasti S, Shahdzi Sh, Mousavi SGhA. [Seroepidemiology Toxoplasma Gondii in pregnant females referring to Ashrafi Isfahani hospital in Khomeinishahrt 1998-2000]. Feyz 2003; 6: 32-7. (In Persian)
18. Mohamadi P, Taherpour A, Mohammadi H. [Seroprevalence of Toxoplasmosis in women during marriage consultation in Sanandaj]. J Infect Trop Dis 2008; 13: 25-29. (In Persian)
19. Daryani A, Sagha M. [Seroepidemiology of toxoplasmosis in women referring to the laboratory of health center in Ardabil for premarital medical examinations]. J Ardabil Univ Med Sci 2004; 4: 19-25. (In Persian)
20. Ataeian A, Tadayon P. [Prevalence of Toxoplasma Gondii antibodies in women of Zanjan Hakim-Hidaji, 1999]. J Zanjan Univ Med Sci 2000; 8: 4-11. (In Persian)
21. Yousefi MR, Sefidgar SAA, Hassanjani-Roshan MR, Ashraf Vaghie SB, Milui Gh, Mostafa Zadeh A. [Seroepidemiological survey in women referred to pre-marriage consultant center in Babol]. Iran J Infect Dis Tropical Med 2005; 10: 31-33. (In Persian)
22. Sharifimoud B, Hashemi Shahri SM, Naderi M. [Investigation of the prevalence of Toxoplasma antibodies in woman during pregnancy in child and mother's clinic in Zahedan]. Iran J Obstet Gyneocol Infertil 2001; 3: 72-75. (In Persian)
23. Mostafavi SN, Atari B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. JRMS 2011; 16: 496-501.
24. Jahani Hashemi H, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried woman in Qazvin, Islamic Republic of Iran. East Med Health J 2010; 16: 24-28.
25. Kamyabi Z, Atapour M. [Investigation of the prevalence of Toxoplasma antibodies in women during marriage consultation in Kerman city]. J Kerman Univ Med Sci 1999; 6: 127-133. (In Persian)
26. Fatta A, Elahi SR, Berenji F, Zarea R, Ghaboli Shahrodi MJ, Ashrafi Abyane H. Evaluation of immunofluorescence antibody (IFA) & immunoperoxidase (IP) tests among 200 pregnant women for Toxoplasmosis. J Mashhad Univ Med Sci 2001; 44: 16-21.
27. Rabiee S, Fallah M, Shirmohammadi A, Serpoush H. Seroepidemiology of Toxoplasma Infection in the Women Aged 15 to 45 Years in Hamadan, West of Iran. J Res Health Sci 2003; 3: 9-12.
28. Song KJ, Shin JC, Shin HJ, Nam HW. Seroprevalence of Toxoplasmosis in Korean pregnant women. Korean J Parasitol 2005; 43: 69-71. [DOI:10.3347/kjp.2005.43.2.69]
29. Ruiz Lopes FM, Gonçalves DD, Mitsuka-Breganó R, Lemos Freire R, Navarro IT. Toxoplasma gondii infection in pregnancy. Braz J Infect Dis 2007; 11: 495-506.
30. Âjami A, Sharif M, Saffar MJ, Zyaee H. [Serological study of Toxoplasmosis in women referred to Medical Health Laboratory before marriage, Mazandaran, 2000]. J Mazandaran Univ Med Sci 2001; 11: 51-56. (In Persian)
31. Meerburg BG, Kijlstra A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res 2009; 105: 17-24. [DOI:10.1007/s00436-009-1447-4]
32. Buchy P, Follezou JY, Lien TX, An TT, Tram LT, Tri DV, et al. Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh city) and pregnant women (NhaTrang). Bull Soc Pathol Exot 2003; 96: 46-47.
33. Akoijam BS, Shashikant, Singh S, Kapoor SK. Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. J Indian Med Assoc 2002; 100: 591-592.
34. Singh S, Pandit AJ. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol 2004; 52: 276-283. [DOI:10.1111/j.1600-0897.2004.00222.x]
35. Khurana S, Bagga R, Aggarwal A, Lyngdoh V, Shivapriya, Diddi K, et al. Serological screening for antenatal toxoplasmainfection in India. Indian J Med Microbiol 2010; 28: 143-146. [DOI:10.4103/0255-0857.62492]
36. Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol 2003; 23: 618-624. [DOI:10.1080/01443610310001604376]
37. Rai SK, Shibata H, Sumi K, Rai G, Rai N, Manandhar R, et al. Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health 1998; 29: 739-743.
38. Harma M, Harma M, Gungen N, Demir N. Toxoplasmosis in pregnant women inSanliurfa, southeastern Anatolia city, Turkey. J Egypt Soc Parasitol 2004; 34: 519-525.
39. Abu-Madi MA, Behnke JM, Dabritz HA. Toxoplasma gondiiseropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. Am J Trop Med Hyg 2010; 82: 626-633. [DOI:10.4269/ajtmh.2010.09-0530]
40. Bouhamdan SF, Bitar LK, Saghir HJ, Bayan A, Araj GF. Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut. J Med Liban 2010; 58: 8-11.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
